Drug
Ammoxetine hydrochloride enteric-coated tablets
Ammoxetine hydrochloride enteric-coated tablets is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_1
4
80%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 14 (80.0%)
Phase 21 (20.0%)
Trials by Status
completed360%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects
NCT07508462
completedphase_1
Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets
NCT07508501
unknownphase_2
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT05018013
unknownphase_1
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject
NCT03850834
completedphase_1
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects
NCT03456388
Clinical Trials (5)
Showing 5 of 5 trials
NCT07508462Phase 1
A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects
NCT07508501Phase 1
Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets
NCT05018013Phase 2
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT03850834Phase 1
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject
NCT03456388Phase 1
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5